Comparative Analysis of National Drug Policies - Second Workshop Geneva, 10-13 June 1996 - EDM Research Series No. 025
(1997; 175 pages) View the PDF document
Table of Contents
View the documentExecutive summary
View the documentI. Introduction
Open this folder and view contentsII. Background on the research project
Open this folder and view contentsIII. Second workshop
Open this folder and view contentsIV. Preliminary findings
Open this folder and view contentsV. Conclusions of the workshop and follow-up plans
Open this folder and view contentsAnnex 1: Research proposal
View the documentAnnex 2: List of participants
View the documentAnnex 3: Agenda
View the documentAnnex 4: Questionnaire on NDP performance assessment
Close this folderAnnex 5: Achievements of the national drug policies in the 12 countries
View the documentBulgaria
View the documentChad
View the documentColombia
View the documentGuinea
View the documentIndia
View the documentMali
View the documentPhilippines
View the documentSri Lanka
View the documentThailand
View the documentViet Nam
View the documentZambia
View the documentZimbabwe
View the documentAnnex 6: Consolidated tables
View the documentOther documents in the DAP Research Series
 

Zimbabwe

Achievement of NDP

ZIMBABWE

1. Has the policy achieved the objectives of:

• availability of essential drugs?


1


2


3



5

• accessibility to essential drugs?


1


2


3



5

• quality of drugs?


1


2



4


5

• rational use of drugs?


1


2


3



5

2. Which components of the policy work and which ones do not work (policy structures and processes)?

a. Legislation and regulation

Structure


1


2


3



5


Process


1



3


4


5













b. Essential drugs selection and drug registration

Structure


1


2


3


4



Process


1


2


3



5













c. Drug allocation in the health budget/public
sector financing policy

Structure


1


2



4


5


Process


1


2


3



5













d. Public sector procurement procedures

Structure


1


2



4


5


Process


1


2


3



5













e. Public sector distribution and logistics

Structure


1


2


3



5


Process


1


2



4


5













f. Pricing policy

Structure


1



3


4


5


Process


1


2


3



5













g. Information and continuing education on drug use

Structure


1



3


4


5


Process


1


2



4


5

The correct number is circled.

1 = does not work
5 = works very well

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: March 20, 2014